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Food intake is detected by the chemical senses of taste and smell and subsequently by chemosensory
cells in the gastrointestinal tract that link the composition of ingested foods to feedback circuits controlling
gut motility/secretion, appetite, and peripheral nutrient disposal. G-protein-coupled receptors responsive
to a range of nutrients and other food components have been identified, and many are localized to intestinal
chemosensory cells, eliciting hormonal and neuronal signaling to the brain and periphery. This review
examines the role of G-protein-coupled receptors as signaling molecules in the gut, with a particular focus
on pathways relevant to appetite and glucose homeostasis.Introduction
Mammals are dependent on food as sources for energy and
biochemical building blocks, and two of our major senses,
taste and olfaction, are employed in, or even dedicated to,
distinguishing beneficial from detrimental food. Three of the
five basic tastes—sweet, bitter, and umami (‘‘savory’’)—have
been linked to the expression of specific G-protein-coupled
receptors (GPCRs), dubbed ‘‘taste receptors,’’ on the lingual
taste buds, and smell is dependent on the use of several
hundred olfactory GPCRs. It has become clear, however,
that beyond these conscious quality assessments the body
also evaluates the composition of food at later time points
during its passage through the digestive tract, and that
this has a major impact on appetite and the coordination of
peripheral nutrient disposal. This review will focus on the
roles of GPCRs in intestinal chemosensing circuits, particu-
larly as this relates to the control of satiety and glucose
homeostasis.
The recent finding that ‘‘taste’’ and ‘‘olfactory’’ receptors
seem also to be expressed in the gut epithelium easily gives
itself to a metaphoric ‘‘tasting’’ and ‘‘smelling’’ of the intestinal
lumenal contents, although this assessment does not reach
our awareness. In the olfactory system, receptors are arranged
in a ‘‘combinatorial receptor coding scheme,’’ in which one
receptor recognizes multiple odorants and one odorant is
recognized by multiple receptors (Malnic et al., 1999), and the
output is further modified according to the identity of individual
sensory neurons. While the level of complexity in the gastroin-
testinal sensory system remains to be established, it seems
plausible that it may utilize a similarly sophisticated encoding
system to discriminate the identities and concentrations of
components of the lumenal chyme, as well as the location
along the gastrointestinal (GI) tract, to generate a multifaceted
response to ingested food. Although the number of GPCRs
involved in GI detection of food intake is unlikely to rival that
of the olfactory system, it already seems clear that individual
nutrients can similarly activate multiple overlapping signaling
pathways.Intestinal Chemosensing Cells
Chemosensation in the gut is considered to occur in specialized
epithelial cells (Figure 1), the enteroendocrine and tuft cells,
more reminiscent of the relatively short-lived taste-responsive
cells on the mammalian tongue (Chandrashekar et al., 2006)
than the free nerve endings of primary olfactory neurons in
the nasal epithelium (DeMaria and Ngai, 2010). Even though
enteroendocrine cells comprise less than 1% of the total GI
epithelial cell number, they form the largest endocrine system
in the body. Collectively they produce over 20 different
hormones acting locally, centrally, and in the periphery. There
are at least ten discrete cell types that make up the enteroendo-
crine family, with each cell type classically described by a distinct
hormonal profile and localization along the length of the gut
(Rindi et al., 2004). Many enteroendocrine cells are classed as
open-type cells, having processes that extend toward the gut
lumen and apical surfaces located within the absorptive brush
border. They make direct contact with ingested and digested
nutrients, thus making these cell types ideally positioned to
act as ‘‘sensors’’ of food intake. The rarer closed-type cells,
such as ghrelin-producing cells in the stomach, are buried in
the mucosa, do not make contact with the gut lumen, and
are believed to respond to mechanical stimuli and neuronal or
paracrine factors.
Tuft cells, also known as brush or caveolated cells, have
hallmarks of a sensory cell type, but differ morphologically
from other secretory GI cells in that they lack electron-dense
granules. Instead they contain caveolae in the apical cytoplasm
and display a tuft of microvilli at the apical pole. It has been
demonstrated recently that they form a distinct lineage of
secretory cells in the GI tract (Gerbe et al., 2011) and express
components of the taste signaling systemaswell as endogenous
opioids (Gerbe et al., 2011; Kokrashvili et al., 2009). Tuft cells
are hypothesized to act as another chemosensory cell type of
the gut, although how they in turn influence the activity of enter-
oendocrine cells, enterocytes, or neurons is unclear.
Detailed molecular studies of the sensory pathways of enter-
oendocrine and tuft cells were limited until recently by theCell Metabolism 15, April 4, 2012 ª2012 Elsevier Inc. 421
Figure 1. Schematic of Chemosensing by
Gustatory Taste and Enteroendocrine Cells
Taste cells and open-type enteroendocrine cells share
many similarities. Morphologically, they have apically
extended processes which make direct contact with in-
gested food. Signal transduction pathways in both cell
types utilize electrogenic channels and/or transporters
and GPCR-mediated signaling cascades to trigger the
release of neurotransmitters and/or gut peptides.
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for cellular physiological studies. Model cell lines are available
for some enteroendocrine cell types and have yielded a wealth
of information about their signaling pathways. GLUTag and
NCI-H716 cells are used as murine and human models for
glucagon-like peptide 1 (GLP-1) secretion, respectively. STC-1
secretes a variety of small intestinal hormones including glucose
dependent insulinotropic polypeptide (GIP), cholecystokinin
(CCK), GLP-1, and secretin. BON cells are used as an entero-
chromaffin cell model. However, the generation of transgenic
mice expressing fluorescent proteins under the control of
hormonal promoters such as proglucagon, GIP, CCK, and
ghrelin, resulting in the cell-specific labeling of L, K, I, and X/A
cells, respectively (Liou et al., 2011a; Parker et al., 2009;
Reimann et al., 2008; Sakata et al., 2009), has led to renewed
interest in, and understanding of, the chemosensing pathways
in these cells.
Nutrient Sensing by GI Chemosensory Cells
Although GPCRs are obvious candidates for chemosensation
in the intestine, they are not the only mechanism. Indeed, even
two of the traditional five taste sensations, salty and sour, work
independently of this class of receptors and instead employ
ion channels that conduct small currents over the plasma
membrane of primary gustatory cells (Chandrashekar et al.,
2006). Considerable evidence supports a role for electrical
activity and voltage-gated Ca2+ channels in gut endocrine cells
(Bjo¨rkqvist et al., 2005; Rogers et al., 2011). Lumenal glucose
detection by L cells appears to involve membrane depolarization
and action potential firing, triggered by the electrogenic activity
of sodium-coupled glucose transporters and leading to
voltage-dependent Ca2+ influx (Reimann et al., 2008). Amino
acids like glutamine and asparagine similarly trigger depolariza-
tion and voltage-dependent Ca2+ entry via their electrogenic
uptake (Tolhurst et al., 2011). Nonetheless, expression analysis
of purified enteroendocrine cell populations from mice, together
with classical immunohistological techniques, have revealed
that they possess enriched levels of a number of GPCRs
that could endow them with the capability to respond to food422 Cell Metabolism 15, April 4, 2012 ª2012 Elsevier Inc.ingestion. In addition, the peptides secreted by
enteroendocrine cells usually target GPCRs
themselves, often expressed on nearby nerve
endings, e.g., of the afferent vagus.
G-Protein-Coupled Receptors
The GPCR family, also known as seven-trans-
membrane receptors, transduce external stimuli
by generating cascade-like signaling pathways.
GPCRs are subdivided into three classes—A, B,and C— based on their sequence homology (Alexander et al.,
2008). Most receptors belong to the rhodopsin-like family A,
many of which are members of the olfactory subgroup. Recep-
tors responsive to short-chain fatty acids (SCFA) also belong
in this family. The secretin-like family B is much smaller and
includes the receptors for hormones such as GLP-1 (glucagon-
related receptors) and GIP. Family Cmembers are characterized
by a large extracellular Venus flytrap ligand-binding domain,
and although commonly known as the metabotropic glutamate
family, this group also includes other nutrient-responsive recep-
tors, such as the taste receptors (T1Rs), the calcium sensing
receptor (CaSR), and GPRC6A.
Extracellular ligand-binding to GPCRs induces conformational
changes that alter a receptor’s interface with cytosolic effec-
tors—primarily the membrane-bound heterotrimeric guanine
nucleotide-binding G-proteins, a, b, and g, which, once acti-
vated, dissociate and stimulate their respective effector path-
ways. The G-proteins are encoded by at least 16 different
a subunit genes, 4 b subunit genes, and 11 g subunit genes.
They are primarily classified based upon their a subunits and
the corresponding downstream signaling pathways they recruit
and can be grouped into four families: Gas, Gai, Gaq, and
Ga12/13. Gas stimulates adenylate cylase (AC) and consequently
elevates the concentration of cyclic adenosine monophosphate
(cAMP) within a cell. Gai inhibits AC and decreases intracellular
cAMP. Gaq stimulates phospholipase C (PLC), leading to the
generation of diacylglycerol (DAG) and inositol triphosphate
(IP3), which respectively activate protein kinase (PK) C and
trigger Ca2+ release from intracellular stores. Ga12/13 couples
to the activation of the small G-protein Rho. The Gbg complex
dissociates from its a subunit upon GTP binding and is capable
of regulating its own effector pathways, including PLC, AC,
phosphatidylinositol 3-kinase (PI3K)g and G-protein-regulated
inwardly rectifying K+ channels. Gbg subunits not only stimulate
downstream pathways of their own, but have also been shown
to modulate the activity of other receptors (Prezeau et al., 2010).
Contrary to the classically held simplicity of this system,
individual receptors probably signal differentially from multi-
ple conformational states and couple to multiple types of
Figure 2. GPCR-Mediated Nutrient Sensing in Enteroendocrine
Cells
A number of GPCRs have been identified as potential ‘‘sensors’’ of lumenal
nutrients. These receptors stimulate the release of gut peptides via coupling to
GaS, which elevates intracellular cAMP, and Gaq, which results in Ca
2+
mobilization and PKC activation. Inhibitory influences are exerted by signaling
through Gai pathways that decrease cAMP levels.
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the binding site occupied, allosteric modulation, receptor oligo-
merization, membrane potential, and the lipid microenvironment
(reviewed in Kenakin and Miller, 2010). Receptor dimerization is
a fundamental property of Class C GPCRs—indeed, the function
of CaSR and T1R receptors requires homo- and heterodimeriza-
tion, respectively (Prezeau et al., 2010). Receptor oligomeriza-
tion not only alters the affinity and efficacy of a ligand but also
the recruitment of downstream signaling pathways (Prezeau
et al., 2010).
Modulation of receptor activity by intracellular molecules,
such as b-arrestins, protein kinases (including PKC, PKA, and
specific G-protein-coupled kinases), and compartmentalization
through interaction with scaffolding proteins, helps to recruit
G-protein-independent signaling pathways and promotes inacti-
vation of GPCR-signaling (reviewed in Kenakin andMiller, 2010).
Prolonged exposure to a ligand can trigger phosphorylation and
desensitization, promoting both the uncoupling of a receptor
from its G-protein and receptor internalization. Activation of
one receptor can also lead to phosphorylation and desensitiza-
tion of another receptor type (heterologous desensitization),
further facilitating crosstalk between different nutrient signaling
pathways.
GPCRs Underlying Primary Lumenal Content Sensing
Carbohydrate
The ‘‘sweet taste’’ of mono- and oligosaccharides in the gusta-
tory buds of the tongue is indisputably dependent on a GPCRdimer comprising T1R2 and T1R3 (reviewed in Chandrashekar
et al., 2006). This pair responds to relatively high concentrations
of glucose (30–1000 mM) and a number of artificial sweeteners
by activating a specialized G-protein, termed gustducin, which
is a member of the Gai family. Gustducin is thought to stimulate
phosphodiesterase and thus result in cyclic nucleotide degrada-
tion, but in parallel the coreleased Gbg subunits activate PLCb2,
leading to IP3-mediated Ca
2+ release (Chandrashekar et al.,
2006). The consequent elevation of cytoplasmic Ca2+ activates
the Ca2+-sensitive transient receptor potential channel M5
(TRPM5) triggering membrane depolarization and activation of
voltage-gated Ca2+ channels. The finding that components of
this signaling cascade are also expressed in the intestinal epithe-
lium has led to the suggestion that this mechanism is preserved
in enteroendocrine cells (Figure 2), although its significance
and physiological role are under dispute.
One of the most prominent effects of ingested glucose is the
incretin effect. Two hormones, GIP and GLP-1, are secreted
from intestinal K and L cells, respectively, when these open-
type endocrine cells encounter glucose in the intestinal lumen.
Both hormones boost glucose-dependent secretion of insulin
from the pancreatic b cell, thus ensuring efficient buffering of
blood glucose after a carbohydrate-rich meal. Given its respon-
siveness to glucose ingestion and its therapeutic potential for
treating type 2 diabetes and obesity, many studies investigating
the function of sweet taste receptors in the gut have focused on
their role in GLP-1 secretion. In both human and rodent GLP-1-
secreting cell lines, artificial sweeteners have been shown to
stimulate GLP-1 release (Jang et al., 2007), and in gustducin
knockout mice, glucose-mediated GLP-1 release was signifi-
cantly attenuated. However, artificial sweeteners failed to
stimulate GLP-1 release from murine primary intestinal cultures
(Reimann et al., 2008), and no enrichment of tas1R2, tas1R3,
or a-gustducin mRNA was observed in purified populations of
L or K cells (Parker et al., 2009; Reimann et al., 2008). In vivo
data have also raised serious doubts about the physiological
relevance of sweet taste receptors for GLP-1 release, as
a number of studies have now shown that ingestion of a range
of sweeteners did not elevate plasma incretin levels or modify
the rate of gastric emptying in human subjects (Ma et al.,
2010). Sweet taste receptors may not act as the enteroendocrine
glucose sensor underlying incretin release, but in view of their
presence in isolated gut cells and the observed effect of sweet
tastants on glucose uptake (Margolskee et al., 2007), further
work is required to clarify their role in GI signaling.
Protein
Protein-rich meals and products of protein digestion have been
shown to stimulate enteroendocrine hormone release in vivo
(Elliott et al., 1993) and in vitro (Ne´moz-Gaillard et al., 1998; Tol-
hurst et al., 2011). As for other nutrients, both GPCR-dependent
and -independent pathways have been implicated in peptide
and amino acid detection. Some amino acids, like glutamine,
have been shown to depolarise enteroendocrine cells as a direct
consequence of their electrogenic uptake via sodium-coupled
transporters, resulting in voltage-gated Ca2+ entry and Ca2+-
dependent stimulation of secretion (Rogers et al., 2011; Tolhurst
et al., 2011). Di- and tripeptides were found to stimulate STC-1
cells transfected with the peptide transporter PEPT1, suggest-
ing that transporter-mediated uptake, potentially coupled to aCell Metabolism 15, April 4, 2012 ª2012 Elsevier Inc. 423
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enteroendocrine stimulation by small peptides (Matsumura
et al., 2005), although a role for this pathway in native enteroen-
docrine cells remains to be established.
A number of GPCRs have been identified as being directly
responsive to amino acids and selected di-, tri-, and tetrapepti-
des. Amino acid-sensitive GPCRs generally have an extracellular
Venus flytrap domain, responsible for ligand binding, and include
the calcium sensing receptor (CaSR), GPCR6A, the heterodi-
meric umami taste receptor T1R1/T1R3, and the metabotropic
glutamate receptors. The weight of evidence implicating these
receptors as GI amino acid sensors is variable, as discussed
below.
Among the GPCRs, the strongest candidate amino acid
sensor in enteroendocrine cells is currently CaSR. This receptor
was originally identified as the Ca2+ sensor in the parathyroid
gland, but is also found throughout the GI tract in a number of
cell types where it has been linked to numerous physiological
responses, including motility, NaCl and water transport, absorp-
tion of Ca2+, and colonic cell differentiation (reviewed in Geibel
and Hebert, 2009). Although best characterized as a sensor of
extracellular Ca2+, including Ca2+ in the gut lumen, it can also
detect aromatic L-amino acids, which result in an allosterically
enhanced sensitivity to extracellular Ca2+ (Saidak et al., 2009).
CaSR is strongly expressed in gastrin-secreting G cells, somato-
statin (Sst)-secreting D cells (Haid et al., 2011), and CCK-
secreting I cells (Liou et al., 2011b) and has thus been proposed
to mediate amino acid triggered secretion of these hormones.
In support of this idea, primary I cells from mice deficient in
CaSR exhibited impaired L-Phe-mediated Ca2+ responses and
CCK release (Liou et al., 2011b). The receptor is predominantly
Gaq coupled, but has also been variously reported to couple to
Gas, Gai, and Ga12/13 (reviewed in Saidak et al., 2009), utilizing
downstream pathways specific to the agonists and cell types
studied. Given its localization throughout the gut and its ability
to change mode of action depending on the cell type, it seems
likely that CaSR plays a significant role in chemosensing in the
GI tract.
The closest evolutionary neighbor of CaSR is the receptor
GPRC6A, which has been found, in heterologous expression
systems, to respond to a broad spectrum of L-amino acids,
particularly basic amino acids (Wellendorph et al., 2005), and
which, like CaSR, exhibits augmentation by physiological
concentrations of Ca2+ and Mg2+. Immunostaining has shown
colocalization of GPRC6A with both gastrin and somatostatin
in the antral gastric mucosa (Haid et al., 2011), but its role in
physiological amino acid sensing by these cells is questionable,
as somatostatin secretion was triggered in vitro by amino acids
favoring CaSR but not GPRC6A (Nakamura et al., 2011).
The T1R1/T1R3 heteromeric receptor underlies umami taste
in the lingual taste buds (reviewed in Chandrashekar et al.,
2006). In heterologous expression systems, rodent T1R1/T1R3
responds broadly to aliphatic L-amino acids and is allosterically
modulated by inosine-5-monophosphate and guanosine 5-
monophosphate, which stabilize the receptor in an active state
and potentiate amino acid responses. The human form of the
receptor, by contrast, is preferentially activated by L-glutamate.
Expression levels of tas1R1 and tas1R3 were not found to be
enriched in K or L cells (Parker et al., 2009; Reimann et al.,424 Cell Metabolism 15, April 4, 2012 ª2012 Elsevier Inc.2008), and this observation extends to the downstream signaling
components plcb2 and trpm5 (F.M.G. and F.R., unpublished
data). One recent report investigated whether either umami
receptors or the closely related Gai-coupled metabotropic
glutamate receptors (mGluR) underlie glutamate sensing in the
stomach, but detected only low tas1R1 expression (Nakamura
et al., 2011). The authors did, however, observe expression of
several members of the mGluR family in a cellular fraction
enriched in small endocrine cells, and they suggest that
these receptors may contribute to amino acid-triggered gastric
acid release via mGluR-dependent inhibition of somatostatin
secretion.
GPR92/93 is not a member of the Venus flytrap family, but is
reportedly activated by peptones. It has been proposed as the
missing link between peptone stimulation and increased CCK
expression and release from I cells, based on experiments in
which the receptor was exogenously overexpressed in STC-1
cells (Choi et al., 2007), although its expression was not found
to be significantly enriched in the native I cell population (Liou
et al., 2011b). GPR92 is predominantly Gaq and Ga12/13 coupled
but has been shown to regulate a variety of downstream
effectors, such as Ca2+, cAMP, PKA, and ERK (Choi et al.,
2007; Lee et al., 2006). It is also known as lysophosphatidic
acid receptor 5 (LPAR5), and, interestingly, Xenopus laevis
oocytes express a homologous native LPA receptor that was
recently shown to be voltage sensitive (Martinez-Pinna et al.,
2010), triggering IP3-mediated Ca
2+ mobilization following
membrane depolarization. Further work is required to elucidate
the role, if any, of GPR92-mediated chemosensing in theGI tract.
Bitter chemicals
There are over 25 members of the bitter taste receptor family
(T2R) belonging to the class A GPCR superfamily, with some
members responding to a broad range of stimuli, but others
being activated by only a select few (Behrens et al., 2009). Bitter
taste receptors have been suggested to mediate a regulatory
role in limiting toxin ingestion and absorption, but there are
a few studies linking bitter compounds to the release of ghrelin,
CCK, and GLP-1 (Janssen et al., 2011; Jeon et al., 2008). More
specifically related to nutrient sensing, T2R1 has been identified
as being sensitive to bitter-tasting di- and tripeptides (Upad-
hyaya et al., 2010), but it has yet to be explored as to whether
this receptor is expressed in the intestine and has any capability
to transduce signals from lumenally digested protein.
Fats and Lipids
Fat ingestion is a potent stimulus for the secretion of a number
of enteroendocrine hormones, including CCK, GLP-1, and GIP
(Elliott et al., 1993; Liddle et al., 1985). Long-chain fatty acids
(LCFA), in particular, inhibit gastric emptying and induce satiety
(Raybould, 1999; Sakata et al., 1996), but SCFA have also
been found to trigger GLP-1 and PYY secretion (Freeland and
Wolever, 2010). There are four principal GPCRs identified to
respond to free fatty acids, FFAR1–FFAR3 andGPR120 (Coving-
ton et al., 2006; Hirasawa et al., 2005). FFAR1 (GPR40) and
GPR120 respond to medium-chain fatty acids to LCFA and are
predominantly Gaq coupled, whereas FFAR2 and FFAR3 are
stimulated by SCFA, produced in the distal gut by fermentation
of dietary fiber. FFAR2 (GPR43) reportedly favors C2–C3 fatty
acids and can couple to Gai/O as well as Gaq, whereas FFAR3
(GPR41) preferentially binds C3–C5 and couples only to Gai/O.
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elevations in Ca2+i and MAPK activation (Covington et al.,
2006; Hirasawa et al., 2005).
The idea that these receptors contribute directly to intestinal
fatty acid chemosensing originates from the finding that their
expression in the GI tract is largely restricted to the enteroendo-
crine cell population. mRNAs for FFAR1 and GPR120 are
enriched in cells expressing GLP-1, GIP, and CCK (Liou et al.,
2011a; Parker et al., 2009; Reimann et al., 2008), and FFAR1
protein colocalized with a range of hormones, including GIP,
GLP-1, ghrelin, CCK, PYY, secretin, serotonin, and substance
P (Edfalk et al., 2008). Of these two LCFA receptors, it remains
unclear which plays the more important role in enteroendocrine
cell fatty acid sensing. FFAR1 null mice displayed reduced
GLP-1 and GIP release in response to dietary fat (Edfalk et al.,
2008) and attenuated linoleic acid-mediated Ca2+ responses
and CCK secretion in isolates of primary I cells (Liou et al.,
2011a). In the STC-1 cell line, however, siRNA against GPR120
but not FFAR1 impaired a-linolenic acid-induced GLP-1 and
CCK release (Hirasawa et al., 2005).
Despite the weight of evidence suggesting that GPCRs would
be ideal sensors of LCFA in GI endocrine cells, this does not
seem to be the whole story. Contrary to the reported fairly strict
Gaq coupling of GPR120 and FFAR1, a-linolenic-induced CCK
release was found to require PKA and L-type Ca2+ channel
activation (Tanaka et al., 2008), and oleic acid-triggered GLP-1
secretion was shown to involve PKCz (Iakoubov et al., 2007)—
amember of the PKC family that is not itself a target of phospho-
lipase C-derived diacylglycerol. The recently proposed ‘‘fat
taste’’ sensor, described in the tongue and involving the non-
G-protein-coupled membrane transporter/receptor CD36, has
also been linked to fat detection in the small intestine (Laugerette
et al., 2005; Schwartz et al., 2008).
The SCFA receptors FFAR2 and FFAR3 have been detected in
colonic L cells by immunostaining (Tazoe et al., 2008), consistent
with reports that nondigestible and fermentable dietary fiber, as
well as SCFA themselves, enhance GLP-1 secretion (Freeland
and Wolever, 2010; Zhou et al., 2008). Activation of an FFAR2-
Gaq-coupled pathway was suggested by recent findings that
SCFAs enhanced intracellular Ca2+ concentrations in primary L
cells and that knockout of FFAR2 impaired both SCFA-triggered
GLP-1 release in vitro and circulating GLP-1 levels in vivo
(Tolhurst et al., 2012). The physiological role of FFAR3 and
the relative importance of these G-protein-coupled receptors
compared with other possible targets of prebiotic supplementa-
tion, however, remain to be established.
Locally Generated Endocannabinoids and Related
Acylethanolamides
While free fatty acids, as primary digestion products of triglycer-
ides, are obvious candidate indicators of fat ingestion, other
fat-derived compoundsmay be generated locally and contribute
to adaptation of the gut to states of feeding and fasting. These
include the endocannabinoids and related acylethanolamines,
such as oleoylethanolamide (OEA), which exhibit activity toward
a range of target proteins including GPCRs (e.g., the classical
cannabinoid receptors CB1 and CB2, GPR119 and GPR55),
ion channels (e.g., TRPV1), and nuclear receptors (e.g., PPARa).
OEA is released from proximal intestinal enterocytes in
response to dietary fat (Schwartz et al., 2008) and has beenassociated with fat-induced satiety. The mechanism underlying
feeding-induced OEA biosynthesis is not fully established, but
was found to be abolished by antagonism of b2 adrenergic
receptors or sympathetic ganglionectomy (Fu et al., 2011) and
might therefore be at least partially under sympathetic control.
OEA in turn recruits sensory vagal afferents and enhances
signaling to the nucleus of the solitary tract of the brainstem
(Rodrı´guez de Fonseca et al., 2001). The finding that OEA and
N-oleoyldopamine are natural ligands for GPR119 (Chu et al.,
2010; Overton et al., 2006), expression of which is largely
restricted to enteroendocrine cells in the gut epithelium (Parker
et al., 2009; Reimann et al., 2008), gave rise to the hypothesis
that these signaling molecules might induce satiety through
GPR119-dependent secretion of anorexogenic gut hormones
such as GLP-1 and PYY. The physiological relevance of OEA
as a natural GPR119 ligand has, however, been questioned, as
levels following a meal may not be sufficient to stimulate the
receptor (EC50 3 mM; Overton et al. [2006]). Other receptors,
such as the transcription factor PPARa, appear thus more likely
candidates to link intestinally generated OEA to the activation of
central satiety circuits (Fu et al., 2003; Schwartz et al., 2008).
More recently, it has been shown that GPR119 is also activated
by 2-oleoylglycerol (2-OG), a natural digestion product of triacyl-
glycerols, likely to reach high concentrations in the intestinal
lumen following fat ingestion (Hansen et al., 2011). Oral adminis-
tration of 2-OG elevated plasmaGLP-1 andGIP levels in humans
(Hansen et al., 2011), thus suggesting that GPR119 may after all
play a key role as an enteroendocrine detector of dietary fat.
While OEA levels fall in the small intestine of fasting rats, the
concentration of the conventional endocannabinoid ligands
N-arachidonoylethanolamine (anandamide, AEA) and 2-arachi-
donoylglycerol (2-AG) has been shown to be inversely modu-
lated by food intake, rising during food deprivation and falling
upon refeeding (Go´mez et al., 2002; Izzo et al., 2009). The clas-
sical cannabinoid receptors CB1 and CB2, which both couple
to Gai/O, are emerging as key players in gut physiology and
pathophysiology. The CB1 receptor gained interest as an anti-
obesity target with the development of rimonobant as an orally
effective CB1 antagonist. Although highly successful in reducing
food intake, the drug was removed from the market because of
its centrally mediated side effects of severe depression and
suicidal thoughts. Interest in the target remains, however, as it
is still unclear whether drug penetration into the central nervous
system is necessary for the anorexic actions of CB1 antagonists
and whether peripherally active drugs could reduce food intake
without causing central side effects. Restricted knockdown of
CB1 in the brain and spinal cord was, however, sufficient to
mimic the therapeutic effects of rimonabant on food intake
and to recapitulate the phenotype of the global CB1 knockout
mouse (Pang et al., 2011). Cannabinoid receptors are expressed
throughout the length of the gut and are predominantly found
in enteric nerves. Presynaptic inhibition of acetylcholine release
from excitatory cholinergic neurons probably underlies the
depressive effect of cannabinoids on GI motility (Aviello et al.,
2008). In myenteric neural networks, CB1 receptors are pro-
posed to regulate constitutive neuronal activity, based on
evidence that spontaneous presynaptic activity was reduced
by stimulation of CB1 receptors and increased by CB1 antago-
nism (Boesmans et al., 2009). Whether CB1, CB2, and GPR55Cell Metabolism 15, April 4, 2012 ª2012 Elsevier Inc. 425
Figure 3. GPCR-Mediated Integration of
Enteroendocrine Signaling Exemplified by an LCell
A number of GPCRs have been identified on GLP-1-
secreting L cells. They are activated by hormones and
neurotransmitters released from other enteroendocrine
cells and the enteric nervous system, and they recruit
the same pathways as the nutrient-sensing GPCRs
depicted in Figure 2. This modulates the release of the
L cell peptides GLP-1, GLP-2, oxyntomodulin, and PYY,
which in turn activate GPCRs shown to be expressed on
afferent nerves.
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tigated.
Bile Acids
Bile acids are released into the gut lumen following gall bladder
contraction and are primarily involved in the emulsification
of dietary lipids. In addition, however, they play important
signaling roles via both nuclear (FXR) receptors (Makishima
et al., 1999) and the G-protein-coupled receptor GPBAR1
(TGR5) (Maruyama et al., 2002). Bile acids are believed to act
as nonnutrient stimuli of enteroendocrine L cells, perhaps
contributing to the enhanced GLP-1 and PYY levels in patients
who have undergone gastric bypass surgery, which results in
enhanced bile acid delivery to the distal gut (Patti et al.,
2009). TGR5 is a GaS-coupled receptor, found to be enriched
in L cell populations (Reimann et al., 2008). Receptor agonists
result in elevated cAMP levels in gut endocrine cells, increased
responsiveness of L cells to glucose, and enhanced GLP-1
secretion from both rodent and human model enteroendocrine
cells (Parker et al., 2012; Thomas et al., 2009). In vivo, lumenal
bile acids were shown to modulate GLP-1 release and intestinal
motility (Adrian et al., 1993), and bile acid-triggered GLP-1
secretion was found to be TGR5 dependent (Thomas et al.,
2009). TGR5 expression was also recently demonstrated in
inhibitory motor neurons in the myenteric plexus (Poole et al.,
2010) and, together with the finding that bile acids significantly
delayed gastric emptying in vivo, the authors proposed that
TGR5 may contribute to the ileal brake, not only by mediating
the release of GLP-1, but also through direct activation of inhib-
itory enteric neurons.
Mechanical Activation of Gut Hormone Secretion
The myriad of pathways by which the GI tract detects food
ingestion includes not only the chemosensory systems outlined426 Cell Metabolism 15, April 4, 2012 ª2012 Elsevier Inc.above, but also responses to mechanical
stretch of the gut wall. Stretch is well recognized
to elicit neural activity via activation of special-
ized nerve endings (Schemann and Mazzuoli,
2010) but has also been reported to stimulate
5-hydroxytryptamine (5-HT or serotonin) secre-
tion from enterochromaffin (EC) cells. The
mechanism is proposed to involve release of
ATP from neighboring enterocytes and EC cells
themselves, which feeds back on the EC cells
through purinergic receptors. Stretch-activated
release of 5-HT from BON cells was mediated
by the stimulatory Gaq-coupled P2Y1 receptors
and inhibited by Gai-coupled P2Y12 receptors(Christofi, 2008). Thus pathways utilizing both intracellular Ca2+
mobilization and cAMP seem to regulate the release of 5-HT in
response to stretch. Some neurons in the submucosal plexus
appear to respond indirectly to mechanical stimulation as
their activation is dependent on secreted 5-HT from EC cells
(Christofi, 2008).
Neurohormonal Regulation of Enteroendocrine Cell
Secretion
While the enteroendocrine and tuft cells probably act as the
primary chemosensory cells of the intestine, the signaling path-
ways targeted by their secreted products can be paracrine,
hormonal, or neuronal. In turn, activity of the primary sensory
cells themselves is continuously fine-tuned by signals from
other enteroendocrine cells and the enteric nervous system,
a network of local nerve fibers and ganglia that communicates
with efferent and afferent branches of the parasympathetic
and sympathetic nerves. Unlike the faster neurotransmission
pathways utilized in the voluntary nervous system, signaling in
these autonomic nerves is primarily GPCR based, employing
acetylcholine and noradrenaline as well as a range of peptide
neurotransmitters including vasoactive intestinal peptide (VIP),
calcitonin gene-related peptide (CGRP), pituitary adenlyate
cyclase-activating protein (PACAP), galanin, and the bombe-
sin-related peptides, neuromedin B (NMB) and gastrin-releasing
peptide (GRP) (Figure 3). Autonomic modulation of gut hormone
release has been demonstrated experimentally in the pig intes-
tine. Here, sympathetic a-adrenergic signals appear to exert an
inhibitory tone on ileal GLP-1 release, which when blocked by
phentolamine unmasked an intrinsic excitatory cholinergic stim-
ulus (Hansen et al., 2004b). This is in agreement with other
studies demonstrating a role for stimulatory M1 and M2 recep-
tors in GLP-1 release from L cell models and for M1 receptors in
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2002).
Efferent autonomic signals play an important role in coordi-
nating early responses to food ingestion, as they can be initiated
by the sight, smell, and taste of food and thus prepare the gut
for nutrient arrival. They contribute, for example, to the initiation
of gastric acid secretion prior to nutrient arrival in the stomach
lumen, by enhancing the release of gastrin and inhibiting that
of Sst. The gastrin-releasing G cells thus exhibit a finely tuned
pattern of secretion, the regulation of which includes anticipatory
cholinergic input (muscarinic M3-Gaq coupled), local Sst
release, and lumenal signals such as Ca2+ and aromatic amino
acids mediated by the CaSR, as discussed above (Schubert,
2010). Recent evidence also suggests that lingual fat detection
can trigger enhanced intestinal biosynthesis of endocannabi-
noids, potentially providing an alternative pathway for neurally
mediated regulation of intestinal responses to ingested nutrients
(DiPatrizio et al., 2011).
As well as the link with anticipatory signals, neural and
hormonal circuits are believed to play a role in crosstalk between
different regions of the GI tract. A proximal-distal loop, for
example, was postulated to account for the rapidity of plasma
GLP-1 elevation following proximal food delivery despite the
predominantly distal location of L cells, and the sensitivity of
GLP-1 release to vagotomy (Rocca and Brubaker, 1999). This
has more recently been questioned, as L cells have been identi-
fied more proximally than previously believed. Proximal signals
could, however, reach the distal L cell population via enteric
neural signals conveyed, for example, by CGRP, PACAP, and
GRP, all of which have been reported as GLP-1 secretagogues
(Herrmann-Rinke et al., 1995; Simpson et al., 2007). In the rodent
(but not in the human), GIP is an effective stimulus of GLP-1
release (Herrmann-Rinke et al., 1995), and as GIP levels rise
rapidly when nutrients contact duodenal K cells, this may
contribute to the early postprandial stimulation of distal L cells.
In humans, it was recently reported that antagonism of CCK1
receptors resulted in blunted oleate-induced GLP-1 secretion,
suggesting the possibility of crosstalk between CCK and GLP-
1 release (Beglinger et al., 2010).
PACAP and VIP, and to a lesser degree CGRP, show a high
degree of colocalization throughout the stomach and intestine.
PACAP and CGRP have been reported to stimulate the release
of GLP-1 (Herrmann-Rinke et al., 1995; Simpson et al., 2007),
and PACAP has additionally been reported to enhance secretion
of a number of other gut hormones, including CCK, PYY, and
histamine (Chang et al., 1996; Vaudry et al., 2000). PACAP is
a ligand at three receptors, PAC1 and VPAC1–2, of which the
latter are also responsive to VIP (Vaudry et al., 2000). NMB and
GRP act as neurotransmitters in the GI tract via their respective
Gaq/11-coupled receptors, BB1 and BB2 (Jensen et al., 2008). A
third member of the BB receptor family, BB3, currently has no
known natural ligand. GRP/BB2 regulates intestinal mucosal
defenses and motility, but also stimulates the release of a range
of intestinal gut peptides, including gastrin, CCK, GIP, and
GLP-1 (Ghatei et al., 1982). BB2 receptor knockout mice exhibit
reduced GLP-1 and insulin secretion in response to gastric
glucose and an impaired satiety response to bombesin. Periph-
eral administration of either NMB or GRP, however, suppressed
food intake in rats, but only the effect of NMB was sensitive tocapsaicin, suggesting that peripheral BB1 receptors also
contribute to the control of food intake (reviewed in Jensen
et al., 2008).
Inhibitory Neural and Paracrine Pathways in the GI Tract
In contrast to the peptide neurotransmitters and hormones
described above, most of which activate Gas- and Gaq-coupled
receptors, there are a number of important inhibitory signaling
pathways in the gastrointestinal tract, mediated through
Gai-coupled receptors. These are exemplified by the endocan-
nabinoid system (CB1, CB2), the neurotransmitter galanin, and
the paracrine/hormonal signal, Sst. Galanin is widely expressed
in the enteric nervous system and has been demonstrated to
inhibit secretion in vitro of a range of enteroendocrine peptides,
including CCK and GLP-1 (Chang et al., 1995; Saı¨fia et al., 1998).
Sst-producing D cells lie closely apposed to their target G cells
in the stomach, providing a tightly coupled modulation of gastrin
release (Schubert, 2010), but in other regions of the GI tract
Sst may act over longer distances as a paracrine or hormonal
modulator. Five Sst receptors (SSTR) have been identified, all
Gai coupled but potentially inhibiting cellular activity via a variety
of downstream intracellular signaling pathways. SSTR5 has
been linked to inhibition of GLP-1 and PYY release from L cells
(Chisholm and Greenberg, 2002), likely due to Gai-mediated
suppression of cAMPi. All SSTRs have, however, been shown
also to regulate MAPK pathways, and activation of SSTR2/5
was found to inhibit nutrient-mediated 5-HT release and ERK
phosphorylation in EC cells (Kidd et al., 2008). Sst inhibits
some Ca2+ channels directly, accounting, for example, for its
inhibitory effect on secretion from ECL cells in the stomach
(Bjo¨rkqvist et al., 2005).
Interestingly, recent evidence suggests that GLP-1 might act
as an autoinhibitory signal on enteroendocrine L cells. The idea
arose from the observations that GLP-1 levels were suppressed
by the GLP-1 mimetic exendin-4 in human volunteers (Edwards
et al., 2001). Expression of GLP-1 receptor mRNA is, however,
not enriched in murine L cells compared with their epithelial
neighbors and is considerably lower in L cells than pancreatic
b cells; in FACS-purified cell populations (Reimann et al.,
2008), expression levels relative to b-actin were (mean [standard
error range]): 0.0002 (0.00008, 0.0006) for small intestinal
L cells versus 2.3 (1.5, 3.5) for pancreatic b cells (F.M.G. and
F.R., unpublished data). As GLP-1 was shown to stimulate Sst
release from the perfused pig intestine (Hansen et al., 2004a),
it appears more likely that GLP-1 exhibits autoinhibition of L cells
by recruitment of Sst or an alternative inhibitory pathway in the
GI tract, rather than by targeting the L cell directly.
GPCRs Downstream of Primary Chemosensory
Cells—Afferent Neural Signaling from the GI Tract
A number of peptides secreted by intestinal chemosensory cells
have central actions on appetite. While direct actions of circu-
lating gut hormones on the central nervous system are beyond
the scope of this review, many intestinal hormones, including
ghrelin, CCK, 5-HT, GLP-1, neurotensin, and PYY, appear to
evoke some of their effects on food intake via afferent neurons
innervating the gastrointestinal tract.
One of the best-studied neural pathways linking the gut
and brain is that underlying the control of food intake by CCK.Cell Metabolism 15, April 4, 2012 ª2012 Elsevier Inc. 427
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release, causing downstream activation of CCK receptors on
afferent nerve fibers. Both CCK1R and CCK2R are expressed
in vagal afferents, but it is generally believed that CCK1R
play the more prominent role in mediating enteric CCK
responses (reviewed in Dockray, 2009). CCK1R, coupled via
Gas and Gaq, stimulates numerous downstream effectors
including elevation of Ca2+i and activation of PKC (Rogers and
Hermann, 2008). Interestingly, it is becoming apparent that
vagal neurons display plasticity in their profile of hormone
receptor expression in response to food ingestion or fasting
(reviewed in Dockray and Burdyga, 2011). Thus, while CCK1R
expression remains fairly stable regardless of food intake,
activation of CCK1R stimulates the expression of Y2-receptors
and the neuropeptide CART, both of which are generally associ-
ated with inhibition of food intake. During periods of fasting, the
same neurons were found to express enhanced levels of the
cannabinoid receptor CB1 and melanin-concentrating hormone
receptor (MCHR1), receptors normally involved in orexigenic
signaling, and both were downregulated by nutrient-stimulated
CCK release.
The anorexigenic effects of CCK, GLP-1, and other peptides
are opposed by ghrelin, acting via its receptor, the growth
hormone secretagogue receptor (GHS1Ra) (Dockray and
Burdyga, 2011). GHS1Ra is a constitutively active G-protein-
coupled receptor, which predominantly activates Gaq (Holliday
et al., 2007). Intravenous administration of acetylated ghrelin
reduces the firing frequency of afferent vagal nerve fibers (Date
et al., 2002). The underlying mechanism remains unclear, but is
postulated to involve a direct action on afferent neurons, as
GHS1Ra has been detected in the nodose ganglion at the
mRNA level (Date et al., 2002) and was observed in the majority
of CCK1R-positive neurons by immunohistochemistry (Burdyga
et al., 2006). The observation that ghrelin prevents nuclear
localization of the transcription factors CREB and EGR1, which
have been implicated in CCK signaling in the afferent vagus,
may provide a partial explanation for the opposing effects of
these hormones on food intake (Dockray and Burdyga, 2011).
The relative importance of the vagus in the orexigenic action
of ghrelin remains, however, controversial, as intraperitoneal
ghrelin has been reported still to promote food intake in vago-
tomized rats (Arnold et al., 2006).
Relatively little is known about the molecular details mediating
the pathways in vagal afferent neurons triggered by other gut
hormones. The short half-life of circulating GLP-1 is used to
argue that the principal physiological targets of this hormone
may lie within the GI tract, potentially on the afferent vagus.
The GLP-1 receptor (GLP1R) has been detected by RT-PCR in
the nodose ganglion of the vagus nerve and immunohistologi-
cally in nerve endings in the wall of the portal vein (Vahl et al.,
2007), as well as in targets of the circulating hormone, such as
the pancreatic islets, heart, and brainstem. Some maintained
activity of GLP-1 and its analogs in GLP1R knockout mice has
led to the belief that there exists a second receptor, as yet
unidentified (Ban et al., 2010). Although GLP1R is predominantly
Gas coupled, GLP-1 has been reported to increase vagal activity,
in part by inhibition of voltage-gated potassium channels, result-
ing in an increase in action potential firing frequency (Gaisano
et al., 2010).428 Cell Metabolism 15, April 4, 2012 ª2012 Elsevier Inc.PYY, which is cosecreted with GLP-1 and GLP-2 from a large
subset of enteroendocrine cells, activates members of the
neuropeptide Y receptor family, coupled to Gai/O. PYY1-36
binds to Y1, Y2, and Y5 receptors, while its degradation product
PYY3-36 (the more anorexigenic form), favors the Y2 receptor
(Batterham and Bloom, 2003). Although Y receptors are ex-
pressed on vagal afferent neurons and peripheral PYY3-36
increases vagal afferent firing (Koda et al., 2005), the relative
contribution of local vagal stimulation by PYY, compared to
central PYY, in mediating satiety remains unclear.
5-HT, released from EC cells and enteric serotonergic
neurons, is an important GI signaling molecule modulating gut
motility, secretion, and sensation (reviewed in Gershon and
Tack, 2007). The ionotropic 5-HT3 receptor plays a key role in
gut 5-HT signaling to the brain, but there are a number of
5-HT-responsive GPCRs expressed throughout the GI tract.
The GaS-coupled receptor 5-HT4 is expressed on presynaptic
nerve terminals and facilitates excitatory cholinergic signaling
to enhanceGImotility. Given that 5-HT4 receptors are expressed
in the myenteric as well as the submucosal plexi, it is hypothe-
sized that signaling through this receptor pathway is in part
from neuronal- rather than EC-secreted 5-HT. Serotonergic
neurons in the enteric nervous system function as interneurons
mediating a variety of secretory and motility reflex pathways in
the gut, via GPCRs such as 5-HT1P and 5-HT7 (Gershon and
Tack, 2007).Conclusion
GPCRs play many important roles in sensing and relaying food-
related signals. They are key to the coordination of appetite,
digestion, and nutrient disposal, and contribute at a number of
levels to the recruitment and integration of pathways linking
the gut, brain, and peripheral tissues. Although our under-
standing of the diversity and complexity of the gut sensory
system is only in its infancy, the therapeutic potential of gut
peptides is already well established, particularly with respect
to the targeting of the GLP-1 axis for the treatment of type 2
diabetes. As GPCRs are the targets for many drugs used in
clinical practice, the receptors in gut chemosensory cells, partic-
ularly those in enteroendocrine L cells, are currently under
scrutiny as potential new pathways for treating diabetes and
obesity. Receptors that have received recent attention as
potential activators of endogenous GLP-1 and PYY release
include FFAR1-3, GPR119, and TGR5. The central importance
of the gut in the control of food intake lends hope to the idea
that further therapeutic successes and nutritional recommenda-
tions will arise from research in this area.ACKNOWLEDGMENTS
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